Company Profile

Mindsciences Inc (AKA: Goblue International LLC~Claritas Mindsciences)
Profile last edited on: 7/17/2023      CAGE: 6T1X5      UEI: ZUDXNMMM1W21

Business Identifier: Digital therapeutics for behavior change
Year Founded
First Award
Latest Award
Program Status
Inactive (Acquired)
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

45 Hickory Drive
Worcester, MA 01609
   (617) 863-7703
Location: Single
Congr. District: 02
County: Worcester

Public Profile

In June 2020 it was announced that Mindsciences had been acquired by Sharecare. Earlier in the year (Feb 2020) the two firms has announced a teamed effort offering an evidence based tobacco cessation program. MindSciences merges evidence-based mindfulness, digital technology and neuroscience to create solutions designed - online guidance programs and applications enabling people to control cravings, to overcome addictions, and to change behaviors. The training principles rely on (1) research into how the brain forms habits (2) evidence-based mindfulness practices based on ancient wisdom traditions that date back thousands of years and have been translated for modern-day use through programs such as mindfulness-based stress reduction (MBSR), and (3) new digital delivery mechanisms. Products include Eat Right Now, which includes app based daily exercises, live coaching, and real time feedback to control cravings and eat right food; Unwinding Anxiety, which include lectures and exercises to reduce anxiety in an individual; and Craving To Quit, which is an app based program to enable people to quit smoking over a period of time.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
Less than .5M
VC funded?
Privately Held
Stock Info
IP Holdings

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2018 1 NIH $339,481
Project Title: Developing a Novel Digital Therapeutic for the Treatment of Generalized Anxiety Disorder

Key People / Management

  Judson A Brewer -- President

  Mark A Mitchnick -- Chief Executive Officer

  Kara Nance -- Senior Medical Advisor

  Josh Roman -- Chief Product Officer